Delivery Order SPE2DB20D1051-SPE2DB23FD7RG
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a medical product used for the treatment of certain eye conditions. The award has a ceiling value of $1,540.71 and a final completion date of December 13, 2023. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a total ceiling value of $18,195.35 and a performance period through January 16, 2025. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,925,986 units of Cyclosporine 0.05% eye emulsion in 30-count packages, with a ceiling value of $1,083.84. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $1,152.00 and covers the delivery of 4566948133 - Cyclosporine 0.05% Eye Emulsion 30s. The contract has a firm fixed price pricing type and an ultimate completion date of January 16, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,758.35 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, with a ceiling value of $5,707.06 and a performance period through January 17, 2025. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,584.83, is for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm fixed-price type, with a period of performance through January 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% Eye Emulsion. The contract has a firm fixed price of $1,826.61 and an ultimate completion date of October 16, 2024. This award is not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $4,820.52 and is a firm fixed-price delivery order, with a period of performance through December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB23FD7RGDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $2,772.90 and an ultimate completion date of April 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary contracting vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 4/25/23 |